# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-011334
Filing Date
2017-02-27
Accepted
2017-02-27 17:02:24
Documents
94
Period of Report
2016-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | v459518_10k.htm | 10-K | 1184214
2 | EXHIBIT 10.9 | v459518_ex10-9.htm | EX-10.9 | 27709
3 | EXHIBIT 10.18 | v459518_ex10-18.htm | EX-10.18 | 93894
4 | EXHIBIT 10.36 | v459518_ex10-36.htm | EX-10.36 | 212869
5 | EXHIBIT 21 | v459518_ex21.htm | EX-21 | 2935
6 | EXHIBIT 23.1 | v459518_ex23-1.htm | EX-23.1 | 8835
7 | EXHIBIT 31.1 | v459518_ex31-1.htm | EX-31.1 | 9386
8 | EXHIBIT 31.2 | v459518_ex31-2.htm | EX-31.2 | 9659
9 | EXHIBIT 32.1 | v459518_ex32-1.htm | EX-32.1 | 3641
10 | EXHIBIT 32.2 | v459518_ex32-2.htm | EX-32.2 | 3525
11 | GRAPHIC | image_001.jpg | GRAPHIC | 34212
12 | GRAPHIC | pg1img1_ex10-9.jpg | GRAPHIC | 15366
| Complete submission text file | 0001144204-17-011334.txt |  | 7387852

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL INSTANCE DOCUMENT | nvax-20161231.xml | EX-101.INS | 1531895
14 | XBRL TAXONOMY EXTENSION SCHEMA | nvax-20161231.xsd | EX-101.SCH | 56708
15 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | nvax-20161231_cal.xml | EX-101.CAL | 62379
16 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nvax-20161231_def.xml | EX-101.DEF | 380264
17 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nvax-20161231_lab.xml | EX-101.LAB | 487794
18 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nvax-20161231_pre.xml | EX-101.PRE | 447434

Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 17642817
SIC: 2836 Biological Products, (No Diagnostic Substances)